If youve looked into GLP-1 therapy for weight loss, youve almost certainly run into both semaglutide and tirzepatide
Note: The U.S
Levy JC, Matthews DR, Hermans MP
Improvements in cardiovascular risk markers including blood pressure, triglycerides, and HbA1c were observed in the Phase 2 trial (Jastreboff et al., NEJM, 2023), all of which are clinically relevant for women, particularly those in midlife and beyond
These behavioral shifts indicate your medication is working correctly, even if water retention or initial inflammation temporarily masks weight loss
We also recommend keeping the vial in its original box or another light-blocking container to protect it from light degradation